BioXcel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Operational Highlights

Go back to BioXcel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Operational Highlights
(NASDAQ: BTAI) Delayed: 0.07 --0 (-0%)
Previous Close $0.07    52 Week High
Open $0.07    52 Week Low
Day High $0.07    P/E N/A 
Day Low $0.07    EPS
Volume 11,000